Clinical Trial Update: Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study [Phase 4]

View source ↗

Summary

Phase 4 trial assessing optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Snippet

Sponsor: Takeshi Morimoto | Conditions: Venous Thrombosis, Neoplasms | Phase 4 | Status: COMPLETED